Resultados de la búsqueda 251-260 of 10610 for Dihydroberberine

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   (Z)-endoxifen belongs to a group of drugs called selective estrogen receptor modulators or "SERM", which help block estrogen from attaching to cancer cells.

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.

3. Enfermedad de las arterias coronarias.

   Publicaciones · Ferri FF. Coronary artery disease. · Coronary heart disease. National Heart, Lung, and Blood Institute. · Usatine RP, et al., eds. · Wilson PWF.

4. Cirugía - Ensayos clínicos - Mayo Clinic

   The objective of this study is to utilize ultra-high-field MR neuroimaging to elucidate the structural and functional anatomy of the human nucleus accumbens ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Jacksonville, Fla. The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer ...

8. Cirugía - Ensayos clínicos - Mayo Clinic

   Rochester, Minn. This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The study will enroll patients with three distinct separate tumor cohorts. The cancers types are colorectal, head and neck carcinoma, and melanoma that are ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...